Optimizing bexarotene therapy for cutaneous T-cell lymphoma - Reply

被引:0
|
作者
Duvic, M [1 ]
机构
[1] MD Anderson Canc Ctr, Dept Dermatol, Houston, TX USA
关键词
D O I
10.1016/j.jaad.2003.04.007
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:482 / 483
页数:2
相关论文
共 50 条
  • [32] Role of bexarotene in the treatment of cutaneous T-cell lymphoma: the clinical and immunological sides
    Pileri, Alessandro
    Delfino, Chiara
    Grandi, Vieri
    Pimpinelli, Nicola
    IMMUNOTHERAPY, 2013, 5 (04) : 427 - 433
  • [33] New insights into the mechanism of action of bexarotene in human cutaneous T-cell lymphoma
    Asumendi, A.
    Nieto-Rementeria, N.
    Izu, R.
    Pérez-Yarza, G.
    Boyano, M. D.
    Ratón, J. A.
    Apraiz, A.
    Díaz-Pérez, J. L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 64 - 64
  • [34] TREATMENT OF CUTANEOUS T-CELL LYMPHOMAS WITH BEXAROTENE
    Lasa, Olatz
    Izu, Rosa
    Acebo, Elvira
    Patricia, Eguino
    Diaz-Perez, Jose L.
    ACTAS DERMO-SIFILIOGRAFICAS, 2005, 96 (10): : 669 - 673
  • [35] Vaccination therapy for cutaneous T-cell lymphoma
    Muche, JM
    Sterry, W
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2002, 27 (07) : 602 - 607
  • [36] Reply to "Recent advances in systemic targeted therapy for cutaneous T-cell lymphoma'
    Amaral, Teresa
    Garbe, Claus
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (14) : 1537 - 1537
  • [37] Photopheresis therapy for cutaneous T-cell lymphoma
    Duvic, M
    Hester, JP
    Lemak, NA
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 35 (04) : 573 - 579
  • [38] Vaccine therapy for cutaneous T-cell lymphoma
    Seo, N
    Furukawa, F
    Tokura, Y
    Takigawa, M
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2003, 17 (06) : 1467 - +
  • [39] ENIGMA OF THERAPY FOR CUTANEOUS T-CELL LYMPHOMA
    JONES, SE
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (03) : 169 - 170
  • [40] Cutaneous T-cell lymphoma (mycosis fungoides) - Reply
    Lorincz, AL
    LANCET, 1996, 348 (9020): : 131 - 131